Incaier, the healthcare arm of Haier Group, has participated in the expo for five consecutive years. This year, more than 50 ...

The United Nations Population Fund (UNFPA) Mexico and EDP Renewables North America LLC have joined forces in a groundbreaking collaborat ...

Havas Health named Anna Maria Marra as CEO of Europe on Tuesday morning, a role in which she will lead and oversee all ...

Havas Health has appointed Anna Maria Marra as CEO of Europe to lead and oversee all aspects of the region's business ...

Pfizer hired Marra all the way back in 2002, at which time the new Havas Health exec had spent a few years working at Merck ...

JP Morgan has recently reduced Organon & Co (OGN) stock to Underweight rating, as announced on September 6, 2024, according to Finviz. Earlier, on November 3, 2023, Goldman had reduced the stock from ...

MAPS 2025 Americas Annual Meeting Annual meeting sessions aligned with MAPS Medical Affairs Competencies Framework provide training oppo ...

Daewoong Pharmaceutical announced on October 31 that it has signed a joint sales agreement with Celltrion Pharm to market CT-P41 ...

BELGRADE - Serbian FM Marko Djuric received an American-Serbian Business Council (ASBC) delegation in Belgrade on Thursday to ...

Despite announcing strong earnings, Organon & Co.'s ( NYSE:OGN ) stock was sluggish. We did some digging and found ...

Organon Philippines, a women’s health company, recently unveiled its Her Health Finder, an online tool that aims to empower ...

On October 30, 2024, Shanghai Henlius Biotech and Organon announced that the FDA has accepted the Biologic License Application (BLA) for HLX14, a proposed biosimilar to PROLIA/XGEVA (denosumab). In ...